The Daily Marijuana Observer Blog | Needham & Co. Reiterates 'Buy' Rating On Cara, Sees 65% Upside | TalkMarkets
Contributor's Links: The Daily Marijuana Observer
Your trusted source for original daily marijuana lifestyle, marijuana business and marijuana stock coverage. Constant Coverage on Cannabis ™

Needham & Co. Reiterates 'Buy' Rating On Cara, Sees 65% Upside

Date: Wednesday, October 4, 2017 11:23 AM EDT

Yesterday, Needham & Co.'s Alan Carr reiterated a 'buy' rating on shares of Cara Therapeutics, Inc.

Read the full article on The Daily Marijuana Observer!

Subscribe to our Cannabinoid Biotech Updates

Other Recent CARA News:

Jim Cramer Interviews CARA CEO on Mad Money

Disclaimer: This and other personal blog posts are not reviewed, monitored or endorsed by TalkMarkets. The content is solely the view of the author and TalkMarkets is not responsible for the content of this post in any way. Our curated content which is handpicked by our editorial team may be viewed here.

Comments

Leave a comment to automatically be entered into our contest to win a free Echo Show.